BioMedNewsBreaks Archive - Page 122 of 261

TuesdayJul 25, 2023 3:16 pm

BioMedNewsBreaks – HippoFi Inc. (ORHB) Announces Launch of PURmarrow 360, Strategic Partnership for Near-Term Commercialization of New Technology

HippoFi (OTC: ORHB) is a leading health care technology company and authority in spinal biologics, focused on the development and distribution of innovative biotech products. The company today announced that, over the last six months, while under a confidential letter of intent (“LOI”) in a strategic partnership, it has designed and formulated a strategic launch of the PURmarrow 360 bone marrow aspirate (“BMA”) device throughout the United States. The product is a natural extension to HippoFi’s robust product line, allowing surgeons to selectively capture highly desired cells from a patient’s own BMA during surgery. The rich marrow enhances the effectiveness…

TuesdayJul 25, 2023 3:09 pm

BioMedNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW), Partners Launch Proven Breakthrough Hair-Booster System in India

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair metabolism and skin therapies, in partnership with its regional distributors, has launched Cosmofix MinoxiBoost in India. JUPW’s distributors are Sanpellegrino Cosmetics Pvt Ltd and Cosmofix Technovation Pvt Ltd, which have exclusive distribution rights to the company’s patented hair-growth technology in 31 countries in Asia and the Middle East including India, the Philippines, Malaysia, Kuwait, Morocco and Saudi Arabia. According to the announcement, MinoxiBoost has been clinically proven to increase essential hair enzymes and is designed to be integrated into the daily minoxidil routine of people seeking increased hair growth. The announcement also noted that based on the distribution agreement,…

MondayJul 24, 2023 3:17 pm

BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) CDMO Services Designed to Meet Needs of Pharmaceutical, Biotechnology Companies of All Sizes

BiondVax (NASDAQ: BVXV) is a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases. The company recently showcased its boutique end-to-end contract development and manufacturing organization (“CDMO”) services and expertise at a leading conference for International Life Science and HealthTech industries, the Biomed Conference, in Tel Aviv. “These CDMO services will allow BiondVax to partner with pharmaceutical companies to provide contract-based drug development and manufacturing services, leveraging its Good Manufacturing Practices (‘GMP’) biologics manufacturing facility in Jerusalem… The company’s CDMO services are designed to meet the needs of pharmaceutical…

FridayJul 21, 2023 11:26 am

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series

InMed Pharmaceuticals (NASDAQ: INM) is a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs. The company today announced that Jerry Griffin, VP of Sales and Marketing for InMed’s subsidiary BayMedica LLC, a leading supplier of bioidentical rare cannabinoids to the health and wellness (“H&W”) market, will be participating in a fireside chat with Water Tower Research on July 25, 2023, at 2:00 p.m. ET. The event is open for all investors with topics that include an overview of BayMedica, its competitive environment and upcoming catalysts, as well as the market dynamics of rare…

ThursdayJul 20, 2023 1:33 pm

BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Results from ‘Groundbreaking’ Sponsored Study Measuring Psychedelic Effects

Cybin (NEO: CYBN) (NYSE American: CYBN), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is reporting on the release of study findings. Cybin sponsored the study, which was conducted by Kernel, a leader in noninvasive neuroimaging. Titled “Measuring acute effects of subanesthetic ketamine on cerebrovascular hemodynamics in humans using TD-fNIRS,” the study was published in “Scientific Reports from the Nature Portfolio of Journals” and evaluated the ability of Kernel’s Flow1 system to capture and analyze brain changes resulting from the administration of a psychoactive substance. According to the announcement, the single-blind, placebo-controlled…

ThursdayJul 20, 2023 12:37 pm

BioMedNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Board Appointments of GBB Drink Lab Founder and President and Beverage Industry Veteran

Jupiter Wellness (NASDAQ: JUPW), a diversified company that supports health and wellness, today announced the appointment of John Gulyas to its board of directors and Rich Pascucci to its advisory board. Both Gulyas and Pascucci are formerly from GBB Drink Lab, creator of Safety Shot, the world’s first rapid blood alcohol detoxification drink recently acquired by Jupiter Wellness. “We are very pleased to have more of the stellar GBB Drink Lab team join Jupiter. John’s track record as a serial entrepreneur and innovator speaks for itself. With his passion, drive and know-how in moving Safety Shot from concept to market…

ThursdayJul 20, 2023 12:01 pm

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today provided a commercial and manufacturing update on its subsidiary BayMedica LLC, a leading supplier of bioidentical rare cannabinoids to the health and wellness (“H&W”) market. Among the highlights, the company reported a 123% quarter-over-quarter increase in revenues. “We are very encouraged to see another strong quarter with (unaudited) revenues in excess of $2.3M, representing our third consecutive quarter with significant revenue growth,” said Eric A. Adams, InMed’s president and CEO. “As demand for minor cannabinoids continues to increase, we…

WednesdayJul 19, 2023 2:44 pm

BioMedNewsBreaks – Institute of Biomedical Research Corp. (MRES) Names Veteran Financial Leader to Advisory Board

Institute of Biomedical Research (OTC: MRES), DBA M2Bio Sciences, has appointed a new member to its advisory board. A distinguished leader and financial and data analytics expert, Adrian Maizey brings a rich background to his new board member role. Maizey has worked with top-tier companies around the world in an array of industries, from the private-equity and hedge-fund spaces to private consumer-retail entities. Currently the CEO of Rand Capital Coffee, the exclusive licensee for Starbucks in Southern Africa, Maizey has also served in leadership positions, including as partner and chief financial, chief operating and chief compliance officer roles, in a…

WednesdayJul 19, 2023 1:42 pm

BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $7.5M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced its entry into definitive agreements with health care-focused institutional investors. The agreements are for the sale and issuance of 7,425,744 shares of the company’s common stock and warrants to purchase up to 7,425,744 shares of common stock at a combined offering price of $1.01 per share of common stock and accompanying warrant, in a registered direct offering priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $0.885 per share, exercisable at the date of issuance…

TuesdayJul 18, 2023 1:37 pm

BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Enters Exclusive License Agreement with University of Pittsburgh

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has signed an exclusive license agreement with the University of Pittsburgh. The agreement grants Genprex worldwide, exclusive rights to a patent application and related technology for a gene therapy targeting both type 1 and type 2 diabetes. The therapy utilizes Pdx1 (“Pdx1”) and MafA (“MafA”) genes controlled by an MafB (“MafB”) promoter and administered through an adeno-associated virus (“AAV”) vector directly into the pancreatic duct. Preclinical data from nonhuman primate models of type 1 diabetes show promising results, with significant decreases…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

BioMedNewsBreaks

BioMedNewsBreaks – HippoFi Inc. (ORHB) Announces Launch of PURmarrow 360, Strategic Partnership for Near-Term Commercialization of New Technology

BioMedNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW), Partners Launch Proven Breakthrough Hair-Booster System in India

BioMedNewsBreaks – BiondVax Pharmaceuticals Ltd.’s (NASDAQ: BVXV) CDMO Services Designed to Meet Needs of Pharmaceutical, Biotechnology Companies of All Sizes

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Water Tower Research Fireside Chat Series

BioMedNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Results from ‘Groundbreaking’ Sponsored Study Measuring Psychedelic Effects

BioMedNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Announces Board Appointments of GBB Drink Lab Founder and President and Beverage Industry Veteran

BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Issues Update on BayMedica Rare Cannabinoid Business

BioMedNewsBreaks – Institute of Biomedical Research Corp. (MRES) Names Veteran Financial Leader to Advisory Board

BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $7.5M Registered Direct Offering

BioMedNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Enters Exclusive License Agreement with University of Pittsburgh

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search